These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28332604)

  • 1. Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters.
    Zuo LJ; Piao YS; Li LX; Yu SY; Guo P; Hu Y; Lian TH; Wang RD; Yu QJ; Jin Z; Wang YJ; Wang XM; Chan P; Chen SD; Wang YJ; Zhang W
    Sci Rep; 2017 Mar; 7():44872. PubMed ID: 28332604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson's disease patients.
    Wu Y; Guo XY; Wei QQ; Ou RW; Song W; Cao B; Zhao B; Shang HF
    Acta Neurol Scand; 2016 May; 133(5):330-7. PubMed ID: 26195131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
    Alves G; Pedersen KF; Bloem BR; Blennow K; Zetterberg H; Borm GF; Dalaker TO; Beyer MK; Aarsland D; Andreasson U; Lange J; Tysnes OB; Zivadinov R; Larsen JP
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):537-43. PubMed ID: 23117496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
    Kang JH; Irwin DJ; Chen-Plotkin AS; Siderowf A; Caspell C; Coffey CS; Waligórska T; Taylor P; Pan S; Frasier M; Marek K; Kieburtz K; Jennings D; Simuni T; Tanner CM; Singleton A; Toga AW; Chowdhury S; Mollenhauer B; Trojanowski JQ; Shaw LM;
    JAMA Neurol; 2013 Oct; 70(10):1277-87. PubMed ID: 23979011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
    Goldman JG; Andrews H; Amara A; Naito A; Alcalay RN; Shaw LM; Taylor P; Xie T; Tuite P; Henchcliffe C; Hogarth P; Frank S; Saint-Hilaire MH; Frasier M; Arnedo V; Reimer AN; Sutherland M; Swanson-Fischer C; Gwinn K; ; Kang UJ
    Mov Disord; 2018 Feb; 33(2):282-288. PubMed ID: 29205509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying axial and cognitive correlates in patients with Parkinson's disease motor subtype using the instrumented Timed Up and Go.
    Herman T; Weiss A; Brozgol M; Giladi N; Hausdorff JM
    Exp Brain Res; 2014 Feb; 232(2):713-21. PubMed ID: 24292517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson's disease.
    Ding J; Zhang J; Wang X; Zhang L; Jiang S; Yuan Y; Li J; Zhu L; Zhang K
    J Neural Transm (Vienna); 2017 Mar; 124(3):353-360. PubMed ID: 27878377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
    Stebbins GT; Goetz CG; Burn DJ; Jankovic J; Khoo TK; Tilley BC
    Mov Disord; 2013 May; 28(5):668-70. PubMed ID: 23408503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.
    Arie L; Herman T; Shema-Shiratzky S; Giladi N; Hausdorff JM
    J Neurol; 2017 Oct; 264(10):2149-2157. PubMed ID: 28879438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural instability and gait are associated with severity and prognosis of Parkinson disease.
    van der Heeden JF; Marinus J; Martinez-Martin P; Rodriguez-Blazquez C; Geraedts VJ; van Hilten JJ
    Neurology; 2016 Jun; 86(24):2243-50. PubMed ID: 27178702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
    Müller ML; Frey KA; Petrou M; Kotagal V; Koeppe RA; Albin RL; Bohnen NI
    Mov Disord; 2013 Mar; 28(3):296-301. PubMed ID: 23239424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF β-amyloid
    Kim R; Lee J; Kim HJ; Kim A; Jang M; Jeon B; Kang UJ
    Neurology; 2019 Jan; 92(1):e40-e47. PubMed ID: 30504429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falls in different types of Parkinson's disease.
    Rudzińska M; Marona M; Bukowczan S; Banaszkiewicz K; Mirek E; Szczudlik A
    Neurol Neurochir Pol; 2007; 41(5):395-403. PubMed ID: 18033639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.
    Kelly VE; Johnson CO; McGough EL; Shumway-Cook A; Horak FB; Chung KA; Espay AJ; Revilla FJ; Devoto J; Wood-Siverio C; Factor SA; Cholerton B; Edwards KL; Peterson AL; Quinn JF; Montine TJ; Zabetian CP; Leverenz JB
    Parkinsonism Relat Disord; 2015 Jul; 21(7):692-7. PubMed ID: 25943529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-task clinical and functional MRI correlates in Parkinson's disease with postural instability and gait disorders.
    Sarasso E; Gardoni A; Piramide N; Volontè MA; Canu E; Tettamanti A; Filippi M; Agosta F
    Parkinsonism Relat Disord; 2021 Oct; 91():88-95. PubMed ID: 34547654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal motor deficit contributions to postural instability and gait disorder in Parkinson's disease.
    Vervoort G; Bengevoord A; Nackaerts E; Heremans E; Vandenberghe W; Nieuwboer A
    Behav Brain Res; 2015; 287():1-7. PubMed ID: 25804361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional connectivity alterations in the motor and fronto-parietal network relate to behavioral heterogeneity in Parkinson's disease.
    Vervoort G; Alaerts K; Bengevoord A; Nackaerts E; Heremans E; Vandenberghe W; Nieuwboer A
    Parkinsonism Relat Disord; 2016 Mar; 24():48-55. PubMed ID: 26924603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale.
    Parashos SA; Elm J; Boyd JT; Chou KL; Dai L; Mari Z; Morgan JC; Sudarsky L; Wielinski CL
    J Parkinsons Dis; 2015; 5(1):67-73. PubMed ID: 25311202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
    Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
    Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.